Open | $15.090 |
Close | $15.050 |
Volume / Avg. | 2.671M / 5.059M |
Day Range | 14.510 - 15.290 |
52 Wk Range | 6.460 - 35.670 |
Market Cap | $2.315B |
P/E Ratio | 169.222 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | % |
Days to Cover | 7.19 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of TG Therapeutics (NASDAQ: TGTX) through any online brokerage.
Other companies in TG Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Syndax Pharmaceuticals (NASDAQ:SNDX), PTC Therapeutics (NASDAQ:PTCT) and Dyne Therapeutics (NASDAQ:DYN).
The latest price target for TG Therapeutics (NASDAQ: TGTX) was reported by HC Wainwright & Co. on Friday, March 1, 2024. The analyst firm set a price target for 45.00 expecting TGTX to rise to within 12 months (a possible 200.20% upside). 25 analyst firms have reported ratings in the last year.
The stock price for TG Therapeutics (NASDAQ: TGTX) is $14.99 last updated March 18, 2024 at 6:48 PM EDT.
There are no upcoming dividends for TG Therapeutics.
TG Therapeutics’s Q1 earnings are confirmed for Monday, April 29, 2024.
There is no upcoming split for TG Therapeutics.
TG Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.